Erica F. Andersen, PhD, FACMG

Research Interests

  • Clinical Cytogenetics Laboratory
  • Heritable Genetic Conditions
  • Hematologic Neoplasms
  • Myelodysplastic Syndromes
  • Histiocytic and Dendritic Cell Neoplasms

Languages

  • English
  • Spanish

Academic Information

  • Departments: Pathology - Assistant Professor (Clinical)
  • Divisions: Clinical Pathology

Board Certification

  • American Board of Medical Genetics (Clinical Cytogenetics)

Academic Office Information

  • 801-583-2787-Ext-2705
  • ARUP Laboratories
    500 S Chipeta Way, Room: MS-H01
    Salt Lake City, UT 84108

Email: erica.f.andersen@aruplab.com

Research Statement

Erica Andersen is an Assistant Professor of Pathology at the University of Utah and Medical Director in the Cytogenetics and Genomic Microarray Laboratories at ARUP Laboratories in Salt Lake City, Utah. She received her PhD in Genetics from the University of Wisconsin-Madison and completed a Clinical Cytogenetics fellowship at the University of Utah. She is board certified by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Dr. Andersen's research interest span both heritable and acquired genetic diseases. She has published novel constitutional genetic findings in association with developmental disorders and is an active memeber of the Clinical Genome Resource (ClinGen) group's efforts to improve constitutional structural variant interpretation in the clinical setting. Her genetic oncology research projects include improving the diagnosis and monitoring for myelodysplastic syndromes and understanding the genetic etiology of rare histiocytic and dendritic cell neoplasms.

Academic Bio

Erica Andersen is an Assistant Professor of Pathology at the University of Utah and Medical Director in the Cytogenetics and Genomic Microarray Laboratories at ARUP Laboratories in Salt Lake City, Utah. She obtained a B.A. in Biology with Emphasis in Genetics, Cell Biology and Development and a Chemistry Core from Macalester College in St. Paul, Minnesota, followed by two years of training as a research technician at the University of Minnesota. Erica received her Ph.D. in Genetics from the University of Wisconsin-Madison and completed postdoctoral fellowship training in Clinical Cytogenetcs at the University of Utah/ARUP Laboratories. She is board certificed by the American Board of Medical Genetics and Genomics and is also a fellow of the American College of Medical Genetics and Genomics.

Education History

Type School Degree
Fellowship University of Utah and ARUP Laboratories
Clinical Cytogenetics
Fellow
Doctoral Training University of Wisconsin-Madison
Genetics
Ph.D.
Undergraduate Macalester College
Major: Biology, Genetics, Cell, and Developmental Biology; Core: Chemistry
B.A.

Selected Publications

Journal Article

  1. Paxton CN, OMalley DP, Bellizzi AM, Alkapalan D, Fedoriw Y, Hornick JL, Perkins SL, South ST, Andersen EF (2017). Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity. doi:10.1038/modpathol.2017.50. Epub 2017 Jul 28. PubMed PMID: 28752840. Mod Pathol, 30(9), 1234-1240.
  2. Andersen EF, Paxton CN, OMalley DP, Louissaint Jr A, Hornick JL, Griffin GK, Fedoriw Y, Kim YS, Weiss LM, Perkins SL, South ST (2017). Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology. doi: 10.1038/modpathol.2017.34. Epub 2017 Jun 16. PubMed PMID: 28621320. Mod Pathol, 30(9), 1321-1334.
  3. Andersen EF, Baldwin EE, Ellingwood S, Smith R, Lamb AN (2014). Xq28 duplication overlapping the int22h-1/int22h-2 region and including RAB39B and CLIC2 in a family with intellectual and developmental disability. Am J Med Genet A, 164(7), 1795-801.
  4. Andersen EF, Carey JC, Earl DL, Corzo D, Suttie M, Hammond P, South ST (2014). Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome. Eur J Hum Genet, 22(4), 464-70.

Abstract

  1. Longhurst MC, Salama M, VanNess M, Kovacsovics TJ, Rodgers GM, Shami PJ, Deininger MW, South ST, Andersen EF (November 2016). Increased sensitivity for detection of genomic abnormalities from plasma cell-free DNA in myelodysplastic syndromes by SNP-Array [Abstract]. The Journal of Molecular Diagnostics, 18(6), 1052.
  2. Andersen EF, Salama ME, Sederberg MC, Toydemir RM, Kovacsovics TJ, Parker CJ, Rodgers GM, Shami PJ, Deininger MW, South ST (April 2015). Evaluating the clinical utility of peripheral blood samples for molecular evaluation of MDS by SNP-A [Abstract]. Leukemia Research, 39(Supp 1), S72.
  3. Andersen EF, Baldwin EE, Ellingswood S, Smith R, Lamb A (2012). Duplication Xq28 and Deletion of SHOX in a family with short stature, intellectual and developmental disability, Poster [Abstract].

Poster

  1. Herriges JC, Brown S, Ozmore J, Janze A, Meck J, Andersen EF (March 2017). The first clinical reports of 14q32 deletions that encompass DICER1 and are associated with DICER1-related tumor development. Poster session presented at 2017 ACMG Annual Clinical Genetics Meeting, Phoenix, AZ.
  2. Ritter DI, Riggs E, Andersen E, Cherry A, Kantarci S, Kearney H, Lorentz CP, Meck JM, Patel A, Plon SE, Raca G, South S, Thorland E, Vanzo R, Pineda-Alvarez D, Aradhya S, Martin CL, on behalf of the Clinical Genome Resource, Co-chairs of ClinGen Dosage WG amp SV Interpretation WG (October 2016). What have genes got to do with it? Analyzing gene content across interpreted CNVs in the Clinical Genome Resource Structural Variation Interpretation Working Group. (Reviewers' Choice Abstract-Top 10%). Poster session presented at American Society of Human Genetics (ASHG) 2016 Annual Meeting, Vancouver, Canada.
  3. Ritter D, Andersen E, Thorland E, Brandt T, Burnside R, Herriges J, Jobanputra V, Kantarci S, Kearney H, Lorentz C, Pineda-Alvarez D, Risheg H, Shen Y, Speevak M, Aradhya S, Riggs E, Martin C, Plon S, on behalf of the Clinical Genome Resource (June 2016). Understanding the differences between loss-of-function intolerance and haploinsufficiency through review of ExAC, DECIPHER and the ClinGen Dosage Sensitivity Map. Poster session presented at Curating the Clinical Genome-ClinGen/DECIPHER 2016 Meeting, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  4. Andersen E, Thorland E, Brandt T, Burnside R, Herriges J, Jobanputra V, Kantarci S, Kearney H, Lorentz C, Pineda-Alvarez D, Ritter D, Risheg H, Rowsey R, Shen Y, Speevak M, Aradhya S, Riggs E, Martin C, on behalf of the Clinical Genome Resource ClinGen (June 2016). Dosage sensitivity curation of pathogenic CNV regions. Poster session presented at Curating the Clinical Genome-ClinGen/DECIPHER 2016 Meeting, Wellcome Genome Campus, Hinxton, Cambridge, UK.
  5. OMalley DP, Andersen EF, Paxton CN, Louissaint A, Hornick JL, Griffin GK, Fedoriw Y, Kim YS, Weiss LM, South S (March 2015). Genetic array analysis of follicular dendritic cell sarcoma. Poster session presented at 2015 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, Boston, MA.
  6. Paxton CN, Bellizzi AM, Alkapalan D, Fedoriw Y, OMalley DP, Perkins SL, South ST, Andersen EF (March 2015). Genomic analysis of juvenile xanthogranuloma. Poster session presented at 2015 ACMG Annual Clinical Genetics Meeting, Salt Lake City, UT.
  7. Martin C, Pascall J, Aradhya S, Kearney H, South S, Andersen E, Horner V, Kaminsky E, Riggs E, Williams E, Thorland E, Church D, Ledbetter D (March 2012). Improving the quality of chromosomal microarray data and interpretation through collaboration and curation. Poster session presented at 2012 ACMG Annual Clinical Genetics Meeting, Charlotte, NC.